Table 1 Demographic and morphometric data.

From: A randomised, non-inferiority study of chloroprocaine 2% and ropivacaine 0.75% in ultrasound-guided axillary block

Demographic data

Chloroprocaine 2%

N = 98

Ropivacaine 0.75%

N = 99

Sex

Female, n (%)

67 (68.4)

56 (56.6)

Male, n (%)

31 (31.6)

43 (43.4)

Age (years)

Mean ± SD

55.7 ± 15.4

56 (56.6)

Median (range)

55.0 (21–89)

43 (43.4)

Body weight (kg)

Mean ± SD

71.77 ± 14.02

72.97 ± 13.13

Median (range)

70.90 (45.0–125)

74.0 (46.0–106.0)

Height (cm)

Mean ± SD

167.3 ± 8.6

169.0 ± 10.0

Median (range)

167.5 (145–198)

168.0 (150–192)

BMI (kg/m2)

Mean ± SD

25.52 ± 3.75

25.45 ± 3.49

Median (range)

25.55 (18.9–31.9)

25.30 (18.0–32.0)

Race

White, n (%)

97 (99.0)

95 (96.0)

Asian, n (%)

0 (0.0)

3 (3.0)

Others: Mestizo, n (%)

1 (1.0)

1 (1.0)